MeiraGTx Holdings (MGTX) Other Non Operating Income (2017 - 2026)
MeiraGTx Holdings' (MGTX) quarterly Other Non Operating Income came in at -$8.6 million in Q4 2025, down 55.64% YoY from -$19.4 million in Q4 2024, and down 452.44% on a QoQ basis from -$1.6 million in Q3 2025.
Analysis
MeiraGTx Holdings (MGTX) Other Non Operating Income (2017 - 2026) Analysis & Trends
MeiraGTx Holdings (MGTX) has 9 years of Other Non Operating Income data on file, last reported at -$8.6 million in Q4 2025.
- Quarterly Other Non Operating Income fell 55.64% year-over-year to -$8.6 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $2.1 million (up 174.36% YoY) and the FY2025 annual result came in at $2.1 million, up 174.36% from the prior year.
- Other Non Operating Income slipped to -$8.6 million in Q4 2025, from -$1.6 million in the prior quarter.
- In the past five years, Other Non Operating Income ranged from a high of $9.2 million in Q4 2023 to a low of -$12.8 million in Q3 2022.
- A 5-year average of -$1.5 million and a median of -$1.0 million in 2024 frame the typical range for Other Non Operating Income.
- Annual changes were most pronounced in 2022 — Other Non Operating Income slumped 2836.48% — and 2025, when it soared 3136.62%.
- Tracing MGTX's Other Non Operating Income over 5 years: stood at $4.2 million in 2021, then sank by 341.65% to -$10.1 million in 2022, then surged by 191.85% to $9.2 million in 2023, then sank by 159.8% to -$5.5 million in 2024, then sank by 55.64% to -$8.6 million in 2025.
- The last three Other Non Operating Income figures came in at -$8.6 million (Q4 2025), -$1.6 million (Q3 2025), and $8.6 million (Q2 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | MeiraGTx Holdings | 1.27 Bn | 1.13 Bn | 315.67 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -5.22 Mn |
| Dec 31, 2025 | -8.61 Mn |
| Sep 30, 2025 | -1.56 Mn |
| Jun 30, 2025 | 8.62 Mn |
| Mar 31, 2025 | 3.69 Mn |
| Dec 31, 2024 | -5.53 Mn |
| Sep 30, 2024 | 3.46 Mn |
| Jun 30, 2024 | -284,000.00 |
| Mar 31, 2024 | -535,000.00 |
| Dec 31, 2023 | 12.22 Mn |
| Sep 30, 2023 | -8.68 Mn |
| Jun 30, 2023 | 1.91 Mn |
| Mar 31, 2023 | 3.86 Mn |
| Dec 31, 2022 | 16.46 Mn |
| Sep 30, 2022 | -12.84 Mn |
| Jun 30, 2022 | -10.43 Mn |
| Mar 31, 2022 | -2.65 Mn |
| Dec 31, 2021 | -1.69 Mn |
| Sep 30, 2021 | -3.37 Mn |
| Jun 30, 2021 | 381,000.00 |